ESPR - Esperion Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$3.19
DETAILS
HIGH:
$3.28
LOW:
$3.16
MEDIAN:
$3.16
CONSENSUS:
$3.19
UPSIDE:
1.92%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue | 403.1 | 332.3 | 116.3 | 75.5 | 78.4 | 227.5 | 148.4 | 184.5 | 0 | 0 | 0 | 0 | 4,977.0 | 0 | 0 | 0 | 0 | 0.0 | 0 |
| Cost of Revenue | 129.2 | 68.6 | 43.3 | 27.0 | 14.2 | 2.4 | 0 | 0.3 | 0.3 | 0.3 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.8 | 0.7 |
| Gross Profit | 273.9 | 263.7 | 73.1 | 48.5 | 64.2 | 225.2 | 148.4 | 184.2 | (0.3) | (0.3) | (0.2) | 0 | 4,977.0 | 0 | 0 | 0 | 0 | (0.8) | (0.7) |
| Operating Expenses | |||||||||||||||||||
| R&D Expenses | 47.9 | 46.2 | 86.1 | 118.9 | 106.0 | 146.9 | 175.6 | 171.5 | 147.6 | 57.9 | 29.8 | 25.3 | 16.0 | 8.0 | 7.8 | 22.0 | 21.5 | 21.8 | 8.5 |
| SG&A Expenses | 165.8 | 163.1 | 142.5 | 109.1 | 185.0 | 199.6 | 65.9 | 33.1 | 21.4 | 18.3 | 20.2 | 10.9 | 6.7 | 2.2 | 2.4 | 6.0 | 5.0 | 2.9 | 2.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.2 | (0.1) | (0.1) | 0 | 0 | 5.0 | 3.2 |
| Operating Expenses | 213.6 | 209.3 | 228.6 | 228.0 | 291.0 | 346.6 | 241.5 | 204.6 | 169.0 | 76.2 | 50.0 | 36.2 | 22.8 | 10.2 | 10.2 | 29.2 | 29.3 | 26.8 | 11.7 |
| Operating Income | |||||||||||||||||||
| Operating Income | 60.3 | 54.4 | (155.6) | (179.5) | (226.7) | (121.4) | (93.1) | (204.6) | (169.0) | (76.2) | (50.0) | (36.2) | (22.8) | (10.2) | (10.2) | (27.9) | (27.3) | (27.6) | (12.4) |
| Interest Expense | 84.6 | 59.3 | 59.0 | 56.8 | 46.4 | 22.7 | 8.1 | 0.1 | 0.2 | 0.4 | 0.5 | 0.3 | 0.9 | 1.5 | 0.6 | 0 | 0 | 0 | 0 |
| Interest Income | 3.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | |||||||||||||||||||
| EBITDA | 60.3 | 7.6 | (150.1) | (176.3) | (222.1) | (120.3) | (88.7) | (204.3) | (166.5) | (74.3) | (49.0) | (36.1) | (22.7) | (10.1) | (10.1) | (27.2) | (26.8) | (25.5) | (11.7) |
| EBIT | 60.3 | 7.5 | (150.3) | (176.8) | (222.8) | (120.9) | (89.0) | (204.6) | (166.8) | (74.6) | (49.3) | (36.2) | (25.2) | (10.3) | (10.2) | 0 | 0 | (27.6) | (12.4) |
| Income Before Tax | (20.8) | (51.7) | (209.2) | (233.7) | (269.1) | (143.6) | (97.2) | (201.8) | (167.0) | (75.0) | (49.8) | (36.4) | (26.1) | (11.7) | (10.8) | (28.7) | (24.9) | (31.4) | 0 |
| Income Tax Expense | 1.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0 | 0 | 0 | 0 | 0 | 4.1 | (0.3) |
| Net Income | (22.7) | (51.7) | (209.2) | (233.7) | (269.1) | (143.6) | (97.2) | (201.8) | (167.0) | (75.0) | (49.8) | (36.4) | (26.1) | (11.7) | (10.8) | (28.7) | (24.9) | (27.6) | (10.7) |
| Per Share Data | |||||||||||||||||||
| EPS (Basic) | -0.11 | -0.28 | -2.03 | -4.33 | -11.03 | -6.05 | -4.02 | -7.54 | -6.98 | -3.33 | -2.26 | -2.22 | -1.71 | -1.22 | -1.13 | -6.86 | -6.38 | -9.35 | -7.94 |
| EPS (Diluted) | -0.11 | -0.28 | -2.03 | -4.33 | -11.03 | -6.05 | -4.02 | -7.54 | -6.98 | -3.33 | -2.26 | -2.22 | -1.70 | -1.22 | -1.13 | -6.86 | -6.38 | -9.35 | -7.94 |
| Shares Outstanding | 207.9 | 187.2 | 103.1 | 66.4 | 28.9 | 27.5 | 27.1 | 26.8 | 23.9 | 22.5 | 22.0 | 16.4 | 15.3 | 9.6 | 9.6 | 4.2 | 3.9 | 2.9 | 1.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||
| Cash & Cash Equivalents | 167.9 | 144.8 | 82.2 | 124.8 | 208.9 | 305.0 | 166.1 | 37.0 | 34.5 | 38.2 | 40.5 | 70.3 | 70.2 | 5.9 |
| Short-Term Investments | 0 | 0 | 0 | 42.1 | 50.4 | 0 | 34.7 | 0 | 0 | 0 | 4.4 | 0 | 0 | 0 |
| Net Receivables | 140.2 | 80.1 | 48.5 | 33.7 | 22.9 | 12.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 105.1 | 94.5 | 65.6 | 35.2 | 34.4 | 16.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | (245.3) | 18.0 | 4.5 | 9.9 | 11.2 | 0 | 0.9 | 0 | 0 | 0 | 0 | 0 | 1.1 | 0.1 |
| Total Current Assets | 167.9 | 338.0 | 201.1 | 246.7 | 329.0 | 345.9 | 211.7 | 142.6 | 203.9 | 213.6 | 45.3 | 71.3 | 71.3 | 6.0 |
| Non-Current Assets | ||||||||||||||
| Property, Plant & Equipment | 3.3 | 5.8 | 4.7 | 1.2 | 2.6 | 7.3 | 2.7 | 0.5 | 0.4 | 0.7 | 3.0 | 3.3 | 2.5 | 2.0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.1 | 3.1 | 0 | 0 |
| Intangible Assets | 0.1 | 0.1 | 0.1 | 0 | 0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0 | 0 | 3.5 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 99.3 | 239.2 | 204.3 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | (123.1) | 0 | 0 | 0 | 50 | 0 | 0 | (99.0) | (165.7) | (173.4) | 0.0 | 0.6 | 0.5 | 0 |
| Total Non-Current Assets | 298.0 | 5.8 | 4.7 | 1.3 | 52.6 | 7.4 | 2.7 | 0.8 | 73.9 | 31.6 | 6.1 | 7.1 | 6.5 | 2.0 |
| Total Assets | 465.9 | 343.8 | 205.8 | 247.9 | 381.6 | 353.3 | 214.4 | 143.5 | 277.8 | 245.2 | 51.4 | 78.3 | 77.9 | 8.0 |
| Current Liabilities | ||||||||||||||
| Account Payables | 65.1 | 51.6 | 31.7 | 23.0 | 17.6 | 52.0 | 28.9 | 44.9 | 20.4 | 4.6 | 1.7 | 2.9 | 3.9 | 1.4 |
| Short-Term Debt | 89.7 | 102.2 | 34.8 | 0 | 0 | 0 | 0 | 0 | 1.0 | 1.7 | 1.1 | 0.9 | 0.7 | 0.5 |
| Deferred Revenue | 0 | 8.5 | 25.4 | 3.5 | 5.7 | 1.7 | 2.2 | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 146.0 | 12.7 | 49.2 | 9.1 | 8.8 | 15.2 | 7.8 | 1.9 | 11.0 | 0 | 2.2 | 2.6 | 2.5 | 1.0 |
| Total Current Liabilities | 300.8 | 246.2 | 156.2 | 92.3 | 73.4 | 94.1 | 66.1 | 64.3 | 33.1 | 15.6 | 4.9 | 6.4 | 7.2 | 2.9 |
| Non-Current Liabilities | ||||||||||||||
| Long-Term Debt | 457.6 | 483.7 | 501.5 | 259.9 | 258.3 | 179.4 | 0 | 0 | 0 | 1.0 | 7.7 | 5.5 | 3.0 | 2.3 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 8.7 | 0 | 0 | 218.8 | 245.7 | 172.5 | 127.3 | 0 | 0 | 0 | (7.7) | (5.5) | (3.0) | (0.0) |
| Total Non-Current Liabilities | 467.0 | 486.3 | 504.6 | 479.4 | 505.2 | 355.3 | 128.4 | 0 | 0 | 1.0 | 7.7 | 5.5 | 3.0 | 2.3 |
| Total Liabilities | 767.9 | 732.5 | 660.8 | 571.7 | 578.5 | 449.4 | 194.5 | 64.3 | 33.1 | 16.6 | 12.7 | 11.8 | 10.2 | 5.2 |
| Stockholders' Equity | ||||||||||||||
| Common Stock | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (1,623.7) | (1,601.0) | (1,549.3) | (1,340.0) | (1,106.4) | (838.8) | (695.3) | (598.1) | (396.3) | (229.2) | (94.0) | (65.3) | (40.4) | (12.8) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | (0.0) | (0.0) | 0 | 0.0 | (0.3) | (0.8) | (0.2) | (3.7) | (2.4) | (1.3) | (0.5) |
| Total Stockholders' Equity | (302.0) | (388.7) | (455.0) | (323.8) | (196.9) | (96.1) | 19.9 | (598.1) | 244.7 | 228.6 | 38.7 | 66.5 | 67.7 | 2.8 |
| Total Liabilities & Equity | 465.9 | 343.8 | 205.8 | 247.9 | 381.6 | 353.3 | 214.4 | (533.8) | 277.8 | 245.2 | 51.4 | 78.3 | 77.9 | 8.0 |
| Debt Metrics | ||||||||||||||
| Total Debt | 548 | 591.2 | 540.9 | 260.9 | 260.2 | 185.4 | 1.6 | 0 | 1.0 | 2.7 | 8.8 | 6.3 | 3.7 | 2.8 |
| Net Debt | 380.1 | 446.5 | 458.7 | 136.2 | 51.3 | (119.6) | (164.6) | (37.0) | (33.4) | (35.4) | (31.7) | (63.9) | (66.5) | (3.1) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Net Income | (22.7) | (51.7) | (209.2) | (233.7) | (269.1) | (143.6) | (97.2) | (201.8) | (167.0) | (75.0) | (28.7) | (24.9) | (27.6) | (10.7) |
| Depreciation & Amortization | 0.1 | 0.1 | 0.2 | 0.5 | 0.6 | 0.5 | 0.3 | 0.3 | 0.3 | 0.3 | (1.3) | (2.0) | (2.0) | (0.7) |
| Stock-Based Compensation | 9.9 | 12.0 | 12.0 | 15.2 | 24.3 | 28.4 | 25.9 | 24.0 | 18.6 | 16.0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (14.6) | (60.5) | 13.7 | (3.4) | (52.5) | (4.3) | (7.3) | 29.2 | 16.5 | 10.0 | (0.5) | (1.1) | 3.0 | 1.9 |
| Other Non-Cash Items | 14.3 | 76.6 | 48.0 | 46.5 | 32.9 | 33.8 | 7.9 | (0.2) | 0.0 | 0.0 | 3.9 | 5.2 | 8.7 | 1.6 |
| Operating Cash Flow | (13.1) | (23.7) | (135.5) | (174.8) | (263.8) | (85.2) | (70.3) | (148.6) | (131.3) | (47.7) | (26.6) | (22.8) | (18.0) | (7.9) |
| Investing Activities | ||||||||||||||
| Capital Expenditure | 0 | (0.3) | 0 | 0 | 0 | (13.4) | (1.0) | (0.2) | (0.0) | (0.1) | (1.2) | (2.0) | (1.3) | (1.6) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 12.5 | 0 | 0 | 0 | 0 | 0 | 0 | (0.2) | 0 |
| Purchases of Investments | 0 | 0 | 0 | (59.9) | (50.5) | (4.4) | (34.3) | (25.5) | (219.6) | (197.2) | (37.2) | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 42.5 | 68.0 | 0 | 39.1 | 99.5 | 166.1 | 183.7 | 207.4 | 32.9 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | (12.5) | 0 | 140.6 | (35.8) | 10.2 | 0.0 | (0.1) | (0.5) | 0 |
| Investing Cash Flow | 0 | (0.3) | 42.5 | 8.1 | (50.5) | 21.4 | 64.2 | 140.4 | (35.9) | 10.1 | (5.5) | (2.1) | (2.0) | (1.6) |
| Financing Activities | ||||||||||||||
| Net Debt Issuance | (54.9) | 35.0 | 0 | 0 | (0.4) | 271.6 | 0 | (1.0) | (1.7) | (1.6) | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | (55) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (7.3) | (39.7) | (6.4) | (58.2) | 50.0 | (14.9) | 136.2 | 11.7 | 1.2 | 0.0 | 1.4 | 25.0 | 84.1 | 2.8 |
| Financing Cash Flow | 36.2 | 86.5 | 50.5 | 32.6 | 268.2 | 201.7 | 136.2 | 10.7 | 163.5 | (1.6) | 1.4 | 25.0 | 84.1 | 2.8 |
| Cash Position | ||||||||||||||
| Net Change in Cash | 23.1 | 62.5 | (42.5) | (134.1) | (46.1) | 137.9 | 130.1 | 2.5 | (3.7) | (39.2) | (29.8) | 0.1 | 64.3 | (6.6) |
| Cash at Beginning | 144.8 | 82.2 | 124.8 | 258.9 | 305.0 | 167.1 | 37.0 | 34.5 | 38.2 | 77.3 | 70.3 | 70.2 | 5.9 | 12.5 |
| Cash at End | 167.9 | 144.8 | 82.2 | 124.8 | 258.9 | 305.0 | 167.1 | 37.0 | 34.5 | 38.2 | 40.5 | 70.3 | 70.2 | 5.9 |
| Free Cash Flow | (13.1) | (24.0) | (135.5) | (174.8) | (263.8) | (98.5) | (71.3) | (148.8) | (131.3) | (47.8) | (27.7) | (24.8) | (19.3) | (9.4) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||||
| Revenue | 403.1 | 332.3 | 116.3 | 75.5 | 78.4 | 227.5 | 148.4 | 184.5 | 0 | 0 | 0 | 0 | 4,977.0 | 0 | 0 | 0 | 0 | 0.0 | 0 |
| Gross Profit | 273.9 | 263.7 | 73.1 | 48.5 | 64.2 | 225.2 | 148.4 | 184.2 | (0.3) | (0.3) | (0.2) | 0 | 4,977.0 | 0 | 0 | 0 | 0 | (0.8) | (0.7) |
| Operating Income | 60.3 | 54.4 | (155.6) | (179.5) | (226.7) | (121.4) | (93.1) | (204.6) | (169.0) | (76.2) | (50.0) | (36.2) | (22.8) | (10.2) | (10.2) | (27.9) | (27.3) | (27.6) | (12.4) |
| Net Income | (22.7) | (51.7) | (209.2) | (233.7) | (269.1) | (143.6) | (97.2) | (201.8) | (167.0) | (75.0) | (49.8) | (36.4) | (26.1) | (11.7) | (10.8) | (28.7) | (24.9) | (27.6) | (10.7) |
| EPS (Diluted) | -0.11 | -0.28 | -2.03 | -4.33 | -11.03 | -6.05 | -4.02 | -7.54 | -6.98 | -3.33 | -2.26 | -2.22 | -1.70 | -1.22 | -1.13 | -6.86 | -6.38 | -9.35 | -7.94 |
| Balance Sheet | |||||||||||||||||||
| Cash & Equivalents | 167.9 | 144.8 | 82.2 | 124.8 | 208.9 | 305.0 | 166.1 | 37.0 | 34.5 | 38.2 | 40.5 | 70.3 | 70.2 | 5.9 | |||||
| Total Assets | 465.9 | 343.8 | 205.8 | 247.9 | 381.6 | 353.3 | 214.4 | 143.5 | 277.8 | 245.2 | 51.4 | 78.3 | 77.9 | 8.0 | |||||
| Total Debt | 548 | 591.2 | 540.9 | 260.9 | 260.2 | 185.4 | 1.6 | 0 | 1.0 | 2.7 | 8.8 | 6.3 | 3.7 | 2.8 | |||||
| Stockholders' Equity | (302.0) | (388.7) | (455.0) | (323.8) | (196.9) | (96.1) | 19.9 | (598.1) | 244.7 | 228.6 | 38.7 | 66.5 | 67.7 | 2.8 | |||||
| Cash Flow | |||||||||||||||||||
| Operating Cash Flow | (13.1) | (23.7) | (135.5) | (174.8) | (263.8) | (85.2) | (70.3) | (148.6) | (131.3) | (47.7) | (26.6) | (22.8) | (18.0) | (7.9) | |||||
| Capital Expenditure | 0 | (0.3) | 0 | 0 | 0 | (13.4) | (1.0) | (0.2) | (0.0) | (0.1) | (1.2) | (2.0) | (1.3) | (1.6) | |||||
| Free Cash Flow | (13.1) | (24.0) | (135.5) | (174.8) | (263.8) | (98.5) | (71.3) | (148.8) | (131.3) | (47.8) | (27.7) | (24.8) | (19.3) | (9.4) | |||||